Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




PPIs May Be Cost-Effective in Some Patients Taking Prophylactic Aspirin
Link ID 7717
Title PPIs May Be Cost-Effective in Some Patients Taking Prophylactic Aspirin
Url http://www.medscape.com/viewarticle/579016?src=rss
Description At over-the-counter cost, proton pump inhibitors are cost-effective in average-risk patients taking low-dose aspirin for secondary prevention of coronary heart disease. Medscape Medical News
Category Articles > Business of Medicine
Keywords
Date Aug 14, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. EU Drugs Agency Recommends Approval of Kuvan for Hyperphenylalaninemia
  The European Medicines Agency has backed approval of Kuvan for treating of hyperphenylalaninemia in patients with phenylketonuria, it said on Thursday. Reuters Health Information
Category:   Articles > Business of Medicine


2. Bristol-Myers Begins Cutting Jobs
  Bristol-Myers Squibb Co. said on Friday it has begun cutting jobs as part of a previously announced restructuring by the U.S. drugmaker meant to help bolster earnings growth. Reuters Health Information
Category:   Articles > Business of Medicine


3. China Arrests Leaders of Fake Drug Ring - Xinhua
  Chinese authorities have arrested 10 people they said were responsible for making and selling fake drugs in eastern Jiangsu Province, state media reported on Friday. Reuters Health Information
Category:   Articles > Business of Medicine


4. Novartis Cancer Drug Wins U.S. Priority Review
  An investigational drug from Swiss drugmaker Novartis AG has been granted priority review in the United States as a treatment for advanced kidney cancer. Reuters Health Information
Category:   Articles > Business of Medicine


5. U.S. Prods China on Healthcare, Cites Heparin Loophole
  A U.S. commerce official said on Friday that China did not have the ability or will to regulate its economy properly, allowing the export of a chemical that tainted a blood-thinning agent suspected of killing dozens. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS